Kynam Capital Management »

Ironwood Pharmaceuticals shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $11M 1.6M 6.52
2024-03-31 $14M 1.6M 8.71

More positions owned by Kynam Capital Management

Natera (NTRA)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dynavax Technologies Corp Com New (DVAX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 Call Option (INSM)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Miragen Therapeutics (VRDN)
Wave Life Sciences SHS (WVE)

View all positions for Kynam Capital Management

Top funds holding Ironwood Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Sarissa Capital Management
Pacer Advisors
State Street Corporation
Renaissance Technologies
Armistice Capital
LSV Asset Management
Morgan Stanley
Braidwell
Jacobs Levy Equity Management
Geode Capital Management
Charles Schwab Investment Management
Kynam Capital Management

View all funds holding Ironwood Pharmaceuticals